As long as the Nifty holds the 25,000-24,900 support zone, an upward journey toward 25,200-25,300 is possible in the upcoming ...

Sumeet Bagadia, executive director of Choice Broking, recommended buying two stocks on Tuesday, July 22, after the Nifty ...

On Tuesday, 1915 stocks advanced, 1969 declined and 208 remained unchanged on Bombay Stock Exchange with advance decline ...

Meanwhile, the Nifty Mid-cap index registered a 4.1 per cent rise in the month and a 5.6 per cent return over the past year.

AGI Greenpac share price surged today following the company's robust financial performance in the first quarter of FY26 ...

U.S. stocks moved higher on Monday as optimism around earnings overshadowed any investor fears over the latest developments ...

India's equity markets are projected to remain resilient in H2 2025, with Nifty50 expected to range between 26,300 and 27,500 ...

The domestic equity benchmarks ended higher today, reversing a two-day decline. Gains were driven largely by robust Q1 earnings from major private lenders HDFC Bank and ICICI Bank, which helped offset ...

According to Mandar Bhojane, Senior Technical & Derivative Analyst - Research at Choice Equity Broking Private Limited, the ...

RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are trading in the overbought territory; here's what to expect next.

The S&P 500 and the Nasdaq notched record high closes on Monday, lifted by Alphabet and other megacaps ahead of several ...

Asia-Pacific markets traded mixed on Tuesday, despite overnight gains on the S&P 500 and Nasdaq, driven by optimism over ...